Prostate cancer is the second most common cancer in men worldwide. Despite medical advances in recent years, this type of ...
Programmed cell death-1, or PD-1, has become a headline-grabbing molecule best known for its role in cancer immunotherapies ...
Celldex Therapeutics has halted work on its solid-tumor-focused bispecific as the biotech prioritizes its work in ...
Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for BALVERSA®â–¼ (erdafitinib) as a monotherapy for the treatment ...
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today ...
Eli Lilly and its investors this past week learned a hard lesson: The sky is no longer the limit when it comes to sales of its blockbuster glucagon-like peptide 1 (GLP-1) drugs for diabetes and ...
Study findings suggest the potential to repurpose a drug that is FDA-approved for treating asthma and eczema, to enhance ...
This valuable study uses robust time-dependent microscopy assays to show that during HIV-1 infection, the viral accessory protein Vif causes cell cycle arrest during metaphase and not G2/M as ...
Herpesviruses are common co-pathogens in individuals infected with human immunodeficiency virus (HIV). Herpes simplex virus ...
Jamie Chadwick believes the pathway for a female driver to reach F1 ... F1 Academy has been part of the Formula 1 support programme this year in its second season and received increased television ...
The team further investigated the effects of SUMOylation and found that it regulates a key protein in another well-known pathway, called Hippo. Although the Hippo pathway is known to play a key role ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback